Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A bioassay for mefloquine.

A E Yeo1, K H Rieckmann

  • 1Army Malaria Research Unit, University of Sydney, Ingleburn, Australia.

The Journal of Parasitology
|December 1, 1992
PubMed
Summary

A new bioassay method estimates mefloquine levels in serum. This reliable method correlates well with HPLC, aiding in malaria prevention and treatment assessments in real-world settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The oral health status, practices and knowledge of pregnant women in south-western Sydney.

Australian dental journal·2013
Same author

Measuring perinatal mental health risk.

Archives of women's mental health·2012
Same author

The chequered history of malaria control: are new and better tools the ultimate answer?

Annals of tropical medicine and parasitology·2007
Same author

Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2006
Same author

Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.

Antimicrobial agents and chemotherapy·2005
Same author

Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma.

Acta tropica·2003

Area of Science:

  • Pharmacology
  • Clinical Chemistry
  • Malariology

Background:

  • Mefloquine is a key antimalarial drug.
  • Accurate monitoring of mefloquine serum concentrations is crucial for effective malaria prevention and treatment.
  • Existing methods for mefloquine quantification may have limitations in field settings.

Purpose of the Study:

  • To present a novel bioassay for estimating serum mefloquine concentrations.
  • To validate the bioassay's performance against a standard analytical method.
  • To establish the utility of the bioassay for field-based assessments of mefloquine efficacy.

Main Methods:

  • Development and implementation of a bioassay for mefloquine quantification.
  • Comparison of bioassay results with those obtained from high-performance liquid chromatography (HPLC).
  • Correlation analysis to assess the agreement between the two methods.

Main Results:

  • The developed bioassay accurately estimates serum mefloquine concentrations.
  • A strong positive correlation was observed between bioassay and HPLC measurements.
  • The bioassay demonstrates good reliability for practical application.

Conclusions:

  • The novel bioassay provides a viable method for determining mefloquine serum levels.
  • This bioassay shows excellent agreement with HPLC, suggesting its clinical utility.
  • The method is suitable for assessing mefloquine treatment or prophylaxis failures in field conditions.

Related Experiment Videos